Agios Pharmaceuticals | AGIO - 市值

股票价格
25.32
每天变化
-0.42 -1.63%
每月一次
-14.43%
每年
-14.02%
Q2 预测
24.78


金融业
股票价格
USD
资产
USD 1.3B
现金及等价物
USD 89.13M
销售成本
USD 1.88M
流动资产
USD 942.05M
流动负债
USD 82.21M
债务
USD 44.52M
EBIT
USD -121.58M
EBITDA
USD -115.5M
员工
486
EPS每股收益
USD -1.86
股本和储备
USD 1.19B
销售毛利
USD 18.09M
债务利息支出
USD 1.39B
利息收入
USD 13.37M
贷款资金
USD 1.06M
市值
USD 1.44B
净收入
USD -108.04M
营业费用
USD 141.55M
营业利润
USD -121.58M
普通股股本
USD 58.45M
PE价格收益
3.56
税前利润
USD -109.06M
销售收入
USD 19.97M
销售和管理费用
USD 42.97M
股票
USD 32.92M
贸易债权人
USD 18.36M
应收帐款人
USD 10.58M


市值 更改 日
AbbVie USD 403.83B 5.2B 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Novartis USD 292.21B 26.55B 2025-12
Novartis USD 263.08B 17.01B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12